OR WAIT null SECS
November 11, 2020
Construction on the workshop is currently underway with plans for it to be fully operational by the end of 2021.
The companies will initially develop and design process technologies, single-use systems, and automation, with plans to eventually focus on an expanding process and digital technologies to optimize a continuous manufacturing process.
November 06, 2020
ProteoNic has licensed its protein expression technology, 2G UNic, to Gilead Sciences.
ACG has acquired a significant stake in IQGEN-X, a Mumbai-based start-up contract research organization (CRO).
Lonza has inaugurated its first ADC payload manufacturing suite at the Visp, Switzerland site.
November 05, 2020
Samsung Biologics has adopted Solentim’s cell seeding and cell metric platforms at its new R&D center in San Francisco, CA.
November 04, 2020
Mogrify’s new technology platform, EpiMOGRIFY, can predict cellular switches important for determining cell identity, cell maintenance, directed differentiation, and cell conversion.
With the presentation of research supporting the use of PTA technology, BioSkryb also launched its ResolveDNA platform for commercial use at ASHG 2020, held virtually on Oct. 27–30, 2020.
November 03, 2020
The agreement will provide capacity for the manufacturing of AZD7442, currently being developed for the potential prevention and treatment of COVID-19, at Lonza's Portsmouth, NH site.
The company is investing $64.5 million to open new facilities in Germany and Japan to expand its overall capacity.